In this first newsletter, we wanted to share with you an overview of the use cases for the two diseases we are focusing on, Alzheimer’s disease and lung cancer. The iASiS platform is being built based on different clinical and policy making scenarios for these use cases.
Alzheimer’s disease
In this use case the iASiS partners are working to create a platform that will assist clinicians with the optimal choice of drug to offer patients, and increase the accuracy of diagnosis. Public health policy scenarios are also being developed based on the clinical scenarios, as well as other key areas such as early diagnosis and risk reduction.
Lung cancer scenario
In this use case, iASiS researchers are trying to identify specific patterns in long surviving lung cancer patients, and evaluate the effectiveness of tyrosin-kinase inhibitors in mutated lung cancer patients. A policy making scenario is being developed to address cancer risk associated with environmental exposures, methods for dissemination of information, technology, and cancer registries.
Contents
Welcome
In the spotlight
Meet the iASiS Team
Objectives and progress in our first year
News
Future Events